If all this were not enough, leave it to notorious and self-interested lobbyists, who normally do not care one bit about the public interest, at least in their professional dealings, to tell us that Pfizer’s inversion is a bad thing. Lobbyists have been interviewed saying that they dread the public backlash against an industry that is already well-known for being one that profits off of people who are in no position to fight back in sick people and others who are desperately looking to drug companies to improve their sometimes dire health (Harris, 2015). Lobbyists have claimed that the Pfizer inversion will “change the course of history” for the pharmaceuticals industry, and in a bad way.
Now that the drugs industry has become less profitable
Now that the drugs industry has become less profitable